The most significant data to date come from a phase 2 randomised controlled trial published in the New England Journal of Medicine in 2023 (Jastreboff et al., NEJM 2023)
While clinical development for obesity was discontinued in 2007 after a Phase IIb trial failed to achieve its primary endpoint, the peptide remains a valuable research tool for investigating adipose tissue biology, lipolytic pathways, and receptor-independent signaling mechanisms
Chronic sleep deprivation and elevated stress increase cortisol, promote insulin resistance, stimulate appetite (partially overriding semaglutide), and preferentially promote fat storage in the abdominal area
Nanoceramides help reduce the appearance of wrinkles and other signs of aging, maintaining skin elasticity
At True Jewel Cosmetic Center, our licensed providers take a personalized approach to every Semaglutide treatment plan